SEE MORE. TREAT SMARTER.
LIVE

Serial Number

86764515

Owner

BTG International Limited

Attorney

Lori A. Ruhly

First Use Date

Dec 23, 2015

Filing Date

Sep 22, 2015

Add to watchlist:

No watchlists yet
View on USPTO

SEE MORE. TREAT SMARTER. Trademark

Serial Number: 86764515 • Registration: 5205582

SEE MORE. TREAT SMARTER. is a trademark filed by BTG International Limited on September 22, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment). The application is currently registered and active.

Owner Contact Info

BTG International Limited (35 trademarks)

5 Fleet Place
London EC4M 7RD , GB

Entity Type: 11

Trademark Details

Filing Date

September 22, 2015

Registration Date

May 16, 2017

First Use Anywhere

December 23, 2015

First Use in Commerce

December 23, 2015

Published for Opposition

July 12, 2016

Goods & Services

[Surgical, medical apparatus and instruments, namely, medical device, apparatus and instruments for treating cancer; drug delivery embolisation apparatus, instruments and systems; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system;] embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolization, namely, embolic devices for use in treating cancer and tumors, embolic devices for treating arteriovenous malformations (AVMs) of the body, and embolic devices for use in treating tumors; [ drug delivery embolisation systems; drug delivery apparatus and instruments namely, a drug delivery system comprised of injection syringes and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system;] medical apparatus and instruments for embolization, namely, medical devices in the nature of particles, namely, embolic microspheres for embolization [ ; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus and instruments for use in the circulatory system; surgical and medical apparatus for use in treatment of, arterio-venous malformations; syringes for use in treatment of, arterio-venous malformations ]

Pharmaceutical, medicinal substances, namely, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations and substances for the treatment of thrombosis, embolisms, drug delivery agents, namely, preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolisation; pharmaceutical preparations and substances for embolisation of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; transarterial chemoembolisation pharmaceutical preparations [; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, therapeutic agents for delivery of radioactive materials to target sites within the body for the treatment of cancer ]

[ Education, namely, developing, arranging and conducting educational seminars, workshops and programs and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; providing computer, electronic and online databases featuring information about medical education in the field of healthcare, medicine, medical treatment and patient care; training in the use and operation of pharmaceutical products, pharmaceutical preparations, radiopharmaceutical preparations, medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions, and training programs in the fields of healthcare, the use of pharmaceutical and medical devices, medical research, surgery, medical science, medicine and medical diseases, disorders and related treatments; Educational services, namely, providing non-downloadable webinars in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions and training in the field of health; educational services, namely, providing non-downloadable webinars in the field of health; education services, namely, conducting online and telephonic instruction and courses in the fields of health and medical issues ]

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 16, 2026 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 15, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 15, 2025 C15A
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 9, 2024 NA85
POST REGISTRATION ACTION CORRECTION
Oct 9, 2024 XXXX
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Oct 8, 2024 EROP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 2, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 2, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 2, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 2, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 2, 2024 COAR
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
May 21, 2024 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 20, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Nov 16, 2023 E815
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 16, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 16, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 16, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 16, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 16, 2023 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 16, 2022 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 29, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 29, 2020 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Aug 29, 2020 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 29, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 29, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 29, 2020 COAR
REGISTERED-PRINCIPAL REGISTER
May 16, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 11, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 8, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 17, 2017 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 16, 2017 AITU
USE AMENDMENT FILED
Mar 6, 2017 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 6, 2017 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 6, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 22, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 2, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 2, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 2, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 2, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 16, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 9, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jan 9, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jan 9, 2016 CNRT
ASSIGNED TO EXAMINER
Jan 9, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2015 NWOS
NEW APPLICATION ENTERED
Sep 25, 2015 NWAP